Data Type


Category

+ Show All

Research Area

+ Show All

Platform


Topic

+ Show All

Species

+ Show All

Characteristic


Format


Origin

6403 results sorted by

Hepatocyte Plating Medium (MP)

Hepatic media for the plating of fresh and cryopreserved, human and animal, primary hepatocytes. The medium consists of a basal Medium with a supplement.MP100: Hepatocyte Plating Medium w/Supplement (MP100-1 + MP100-2), 100mlMP250: : Hepatocyte...

An hepatitis B and D virus infection model using human pluripotent stem cell-derived hepatocytes

Current culture systems available for studying hepatitis D virus (HDV) are suboptimal. In this study, we demonstrate that hepatocyte-like cells (HLCs) derived from human pluripotent stem cells (hPSCs) are fully permissive to HDV infection across...
Authors: Huanting Chi, Bingqian Qu, Angga Prawira, Talisa Richardt, Lars Maurer, Jungen Hu, Rebecca M Fu...

An efficient, non-viral arrayed CRISPR screening platform for iPSC-derived myeloid and microglia models

Here, we developed a CRISPR-Cas9 arrayed screen to investigate lipid handling pathways in human induced pluripotent stem cell (iPSC)- derived microglia.We established a robust method for the nucleofection of CRISPR-Cas9 ribonucleoprotein...
Authors: Meier S, Larsen ASG, Wanke F, Mercado N, Mei A, Takacs L, Mracsko ES, Collin L, Kampmann M,...
SST Peer Reviewed

Human Stellate Cell Growth Media

MCST250 is a medium optimized for the culture of human hepatic stellate cells. Storage = - 20 ºC (shelf life is 6 month from date of manufacture)Storage = 2ºC to 8ºC (shelf life is 4 weeks after thawing)

Dental Pulp Stem Cell Media BulletKit

Dental Pulp Stem Cell Media Bulletkit was developped to Dental Pulp derived Mesenchymal Stem Cells without inducing differentiation. 

BH3 mimetics augment cytotoxic T cell killing of acute myeloid leukemia via mitochondrial apoptotic mechanism

Adoptive cell therapy (ACT) can address an unmet clinical need for patients with relapsed/refractory acute myeloid leukemia (AML), but its effect is often modest in the setting of high tumor burden. In this study, we postulated that strategies...
Authors: Saxena K, Ryu E, Hung SH, Singh S, Zhang Q, Zeng Z, Wang Z, Konopleva M, Yee C
SST Peer Reviewed

A Drug Screen using Human iPSC-Derived Hepatocyte-like Cells Reveals Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia

Efforts to identify pharmaceuticals to treat heritable metabolic liver diseases have been hampered by the lack of models. However, cells with hepatocyte characteristics can be produced from induced pluripotent stem cells (iPSCs). Here, we have used...
Authors: Max A Cayo , Sunil K Mallanna, Francesca Di Furio , Ran Jing , Lauren B Tolliver , Matthew...

eCHO™ Medium and Feed

eCHO™ Basal Medium and Feed is a chemically defined, hydrolysate-free, serum-free, and non-animal origin medium for supporting high-density CHO cells in suspension.Improved cell growth and protein yield are achieved when adding the...

TheraPeak® T-VIVO®

TheraPEAK® T-VIVO® Cell Culture Medium is a chemically-defined, non-animal origin (NAO) cell culture medium to culture and grow a variety of hematopoietic cells including:T cells: both dd (Gamma Delta) and aß (Alpha Beta) subpopulationsCAR-T...

An engineered human cardiac tissue model reveals contributions of systemic lupus erythematosus autoantibodies to myocardial injury

Systemic lupus erythematosus (SLE) is a heterogenous autoimmune disease that affects multiple organs, including the heart. The mechanisms of myocardial injury in SLE remain poorly understood. In this study, we engineered human cardiac tissues and...
Authors: Sharon Fleischer, Trevor R. Nash, Manuel A. Tamargo, Roberta I. Lock, Gabriela Venturini, Margaretha...
PAGE 631